The case for cloud in life sciences

McKinsey

As cloud technology matures, life-sciences companies are generating new paths to business value beyond the cost efficiencies that cloud migrations typically target. Insights on Life Sciences Medical products Pharmaceuticals Cloud computing

How digital helps a life sciences leader move at light speed

McKinsey

Insights on Life Sciences PharmaceuticalsPfizer’s Chief Digital and Technology Officer explains how digital is transforming her organization’s ability to bring new medicines to patients at speed and at scale.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Top 10 Growth Opportunities in the Healthcare & Life Sciences Industry

Frost & Sullivan

31, 2022 – The post COVID-19 pandemic recovery and other geopolitical events in 2021 has left the healthcare & life sciences industry in a remarkable position to be ready for 2022 and beyond. San Antonio, TX, – Jan.

Life Sciences’ Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users

Frost & Sullivan

As life sciences companies aim to enhance patients’ treatment experiences and find new biomarkers that aid drug discovery, DTx companies diversify their pipelines by adding new indications, addressing unmet needs.

Life Sciences’ Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users

Frost & Sullivan

As life sciences companies aim to enhance patients’ treatment experiences and find new biomarkers that aid drug discovery, DTx companies diversify their pipelines by adding new indications, addressing unmet needs.

LHS Expert Insights: ESG Issues for Life Science Innovators

LaVoie Health Science Blog

Interviews with our senior practice managers about issues of important to life science innovators. As investments into sustainable companies and funds have surged to new highs, how can biotech and life science companies best position themselves with this burgeoning group of investors.

ArisGlobal Lauded by Frost & Sullivan for Enabling Life Sciences Companies to Accelerate R&D with Its LifeSphere® Platform

Frost & Sullivan

LifeSphere supports hundreds of global life sciences companies to accelerate development, maintain compliance, and streamline collaboration between cross-functional teams. Best Practice Awards Healthcare & Life Sciences Best Practices News Press Releases

Capgemini Applauded by Frost & Sullivan for Enabling Businesses in the Life Sciences Industry to Transform and Manage Their Processes with Its End-to-end Digital Transformation and Technology Services

Frost & Sullivan

January 11, 2022 – Frost & Sullivan analyzed global digital transformation services in the life sciences industry and, based on its findings, recognizes Capgemin i with the 2021 Global Company of the Year Award for digital transformation services within life sciences.

8 Growth Opportunities in the Healthcare and Life Sciences Industry to Watch Out for in 2021

Frost & Sullivan

To help companies identify new avenues for top-line growth and plan for a more fruitful 2021, Frost & Sullivan’s team of industry experts have compiled a complimentary insight: Top 8 Growth Opportunities in the Healthcare and Life Sciences Industry for 2021 – What You Need to Know Now.

What are the biotech investment themes that will shape the industry?

McKinsey

Insights on Life Sciences BiotechnologyFrom 2019 to 2021, venture capitalists plowed $35 billion into biotech companies with advanced platform technologies that could transform the industry.

Health equity: A framework for the epidemiology of care

McKinsey

Pharmaceutical and life sciences companies can unlock new opportunities, help underserved patients, and build a cycle of trust. Insights on Life Sciences Health care reform Pharmaceuticals

Innovation sourcing in biopharma: Four practices to maximize success

McKinsey

Insights on Life Sciences Pharmaceuticals Biotechnology Artificial IntelligenceBiopharma companies’ pipelines are full of assets they source externally to access innovation. Four practices will help ensure their investments flourish at a time of fierce competition.

Building pharma pipelines using a socioeconomic lens

McKinsey

Harnessing advances in science and technology can deliver transformative therapies faster while reducing the socioeconomic burden of disease. Insights on Life Sciences Biotechnology Innovation

CROs and biotech companies: Fine-tuning the partnership

McKinsey

Insights on Life Sciences BiotechnologyEmerging biotechnology companies are less satisfied than large pharmaceutical companies with their contract research organizations (CROs). How can CROs raise their game with this key segment?

A new operating model for pharma: How the pandemic has influenced priorities

McKinsey

Insights on Life Sciences PharmaceuticalsThe COVID-19 pandemic has prompted pharma companies to rethink their organizational strategies. A survey of executives suggests where value might lie.

Better data for better therapies: The case for building health data platforms

McKinsey

Insights on Life Sciences Health care services Health Care PharmaceuticalsHealth data platforms that participants trust could bring an end to today’s reductionist approach to drug development, revolutionizing our understanding of disease.

How biotechs can rethink their strategies after the market downturn

McKinsey

Insights on Life Sciences Health Care BiotechnologyBiotech stocks have taken a hit, but the sector will probably rebound. Companies can navigate the downturn by scrutinizing cash management and financing and rethinking paths to long-term value creation.

Building a global biotech: Taking a first-time launch into international markets

McKinsey

Insights on Life Sciences Biotechnology Globalization StrategyEstablishing an international presence with a first launch is a challenge, but learning from others’ experiences can help biotechs avoid missteps and maximize their chances of success.

The rise of digital marketing in medtech

McKinsey

Insights on Life Sciences Medical products Digital marketing AnalyticsDigital marketing offers medtech companies powerful ways to personalize engagement with healthcare professionals and respond to their changing needs.

Generating real-world evidence at scale using advanced analytics

McKinsey

Insights on Life Sciences Pharmaceuticals AnalyticsAs pharma companies apply advanced analytics to generate new types of evidence, how do they decide which use cases to target and how to scale them up across the business?

The UK biotech sector: The path to global leadership

McKinsey

The United Kingdom is Europe’s leading biotech hub in breakthrough life-sciences start-ups. Insights on Life Sciences Pharmaceuticals Medical products United KingdomHow is this hub maturing relative to its global peers, and what lies ahead on the road to sustainable scale?

Driving sustainable, enterprise-wide performance acceleration

McKinsey

Insights on Life Sciences PharmaceuticalsLeading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains and builds long-term capabilities at the same time.

Getting strategic about new-product submissions in the pharma industry

McKinsey

Insights on Life Sciences PharmaceuticalsBy rethinking the approach to regulatory submissions, pharma companies can reduce timelines and increase their chances of successful product approvals.

Integrated evidence generation: A paradigm shift in biopharma

McKinsey

Insights on Life Sciences Medical products PharmaceuticalsBiopharma companies should consider a new, integrated approach to evidence-generation strategies to better demonstrate the value of therapies to all stakeholders.

Clinical supply chains: How to boost excellence and innovation

McKinsey

Insights on Life Sciences Pharmaceuticals Supply chain managementClinical trials have increased in number and have become more complex, decentralized, and patient-centric. While this puts pressure on clinical drug supply, it also brings new opportunities.

Four ways to make sure your pharma manufacturing strategy delivers value

McKinsey

Insights on Life Sciences Pharmaceuticals Manufacturing StrategyCOVID-19 disruptions have led many pharmas to reassess their manufacturing networks and strategies. We share four ways that pharma companies can optimize manufacturing and avoid common pitfalls.

The dawn of China biopharma innovation

McKinsey

Insights on Life Sciences Pharmaceuticals Medical products ChinaChinese biopharma is making a mark on the global stage as the rapidly evolving regulatory landscape and maturing innovation ecosystem spur significant value creation.

Four ways pharma companies can make their supply chains more resilient

McKinsey

Insights on Life Sciences Pharmaceuticals Supply chain managementPharmaceutical supply chains have become global and complex. With more outsourcing, new modalities, and novel ways to reach patients, it’s critical to ensure that they can withstand shocks.

Germany’s e-health transformation makes uneven progress

McKinsey

Insights on Life Sciences Health Care High Tech & Internet Pharmaceuticals DigitalOur eHealth Monitor report shows solid uptakes of telemedicine and consumer health apps. But e-prescriptions, health data exchange, and patient use of electronic health records are lagging behind.

Transforming biopharma R&D at scale

McKinsey

Insights on Life Sciences PharmaceuticalsTransformations often struggle to scale up and make change stick. To achieve lasting impact, high-performing R&D organizations pay heed to the five outcomes that matter most.

Embedding ‘smart quality’ culture and capabilities in the organization

McKinsey

Insights on Life Sciences Pharmaceuticals Leadership StrategyPharmaceutical and medical-device companies can get the most value from “smart quality” processes enabled with new technologies by adopting a holistic approach to building culture and capabilities.

Viral-vector therapies at scale: Today’s challenges and future opportunities

McKinsey

Insights on Life Sciences PharmaceuticalsViral-vector gene therapies are here to stay. Keeping pace with increasing demand requires consideration of challenges, the potential for standardization, and strategizing for accelerating patient access.

Pfizer’s mix of science and grit alters the course of its COVID-19 response

McKinsey

Insights on Life Sciences Pharmaceuticals Public healthAngela Hwang, Pfizer’s head of biopharmaceuticals, talks about breaking new ground when the pressure is on—and how having a deep company heritage can help.

Accelerating pandemic response efforts: An interview with CEPI’s Richard Hatchett

McKinsey

Insights on Life Sciences Pharmaceuticals Public health LeadershipAmid the COVID-19 crisis, the CEO of the Coalition for Epidemic Preparedness Innovations explains his five-year strategy that includes reducing vaccine timelines.

Forward Thinking on the enduring power of engineering in a digitizing world with Hayaatun Sillem

McKinsey

The first female CEO of the United Kingdom’s Royal Academy of Engineering reflects on the evolving role of engineering in a dematerializing world, its vital role in science and sustainability—and collaborating with a Formula One world champion. Insights on Life Sciences

Pfizer’s mix of science and grit alters the course of COVID-19

McKinsey

Insights on Life Sciences Pharmaceuticals Public healthAngela Hwang, Pfizer’s head of biopharmaceuticals, talks about breaking new ground when the pressure is on—and how having a deep company heritage can help.

Digital Transformation Takes Center Stage at Frost & Sullivan’s MEASA Best Practices Awards

Frost & Sullivan

Best Practice Awards Energy & Environment Best Practices Healthcare & Life Sciences Best Practices ICT Best Practices Mobility Best Practices News Press Releases Best Practices Awards Digital Transformation

Insilico Medicine Applauded by Frost & Sullivan for Enabling Rapid and Cost-Effective Drug Discovery and Development with Its Pharma.AI Platform

Frost & Sullivan

Best Practice Awards Healthcare & Life Sciences Best Practices News Press Releases Asia-Pacific Best Practices Awards Entrepreneurial Company of the Year Frost & Sullivan Awards Insilico MedicineSAN ANTONIO , Mar.

Moderna’s path to vaccine innovation: A talk with CEO Stéphane Bancel

McKinsey

Moderna’s delivery of a COVID-19 vaccine comes on the heels of revolutionary science that may accelerate innovation across the industry well into the future. Insights on Life Sciences Pharmaceuticals Public health Health care services Managing in Uncertainty Innovation

Syapse Awarded 2021 Technology Innovation Leadership Award by Frost & Sullivan for Accelerating Real-world Care Delivery

Frost & Sullivan

It employs deep learning algorithms, and different data science and data knowledge types to generate meaningful real-world evidence (RWE), helping to build a holistic view of the patient journey. Best Practice Awards Healthcare & Life Sciences Best Practices News Press Releases